AcasăAsia Pacific NewsRecommendations announced for influenza vaccine composition for the 2023-2024 northern hemisphere influenza...

Recommendations announced for influenza vaccine composition for the 2023-2024 northern hemisphere influenza season

Published on

The World Health Organization (WHO) today announced the recommendations for the viral composition of influenza vaccines for the 2023-2024 influenza season in the northern hemisphere. The announcement was made at an information session at the end of a 4-day meeting on the Composition of Influenza Virus Vaccines, a meeting that is held twice annually, according to a press release issued by WHO.

WHO organizes these consultations with an advisory group of experts gathered from WHO Collaborating Centres and WHO Essential Regulatory Laboratories to analyse influenza virus surveillance data generated by the WHO Global Influenza Surveillance and Response System. The recommendations issued are used by the national vaccine regulatory agencies and pharmaceutical companies to develop, produce, and license influenza vaccines for the following influenza season. 

The periodic update of viruses contained in influenza vaccines is necessary for the vaccines to be effective due to the constant evolving nature of influenza viruses, including those circulating and infecting humans.

The WHO recommends that quadrivalent vaccines for use in the 2023-2024 northern hemisphere influenza season contain the following:

Egg-based vaccines 

  • an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
  • an A/Darwin/9/2021 (H3N2)-like virus; and
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

Cell culture- or recombinant-based vaccines 

  • an A/Wisconsin/67/2022 (H1N1)pdm09-like virus;
  • an A/Darwin/6/2021 (H3N2)-like virus;
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus; and
  • a B/Phuket/3073/2013 (B/Yamagata lineage)-like virus.

WHO recommends that trivalent vaccines for use in the 2023-2024 influenza season in the northern hemisphere contain the following: 

Egg-based vaccines 

  • an A/Victoria/4897/2022 (H1N1)pdm09-like virus;
  • an A/Darwin/9/2021 (H3N2)-like virus; and
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus.

Cell culture- or recombinant-based vaccines

  • an A/Wisconsin/67/2022 (H1N1)pdm09-like vi;
  • an A/Darwin/6/2021 (H3N2)-like virus; and
  • a B/Austria/1359417/2021 (B/Victoria lineage)-like virus
Proiectul jurnalistic ecopoliticnews.com este un proiect susținut de AGI
- o asociație neguvernamentală, apolitică și non-profit.
Depinde și de tine să susții o presă independentă.

Latest articles

CNAS announces continuity of treatment for oncology patients

The National Health Insurance House (CNAS) assures oncology patients that it continuously monitors the...

IMF expects gradual increase in Romania’s economy and inflation reduction by end of 2026

Romania's economy is expected to grow gradually, driven by much-needed fiscal consolidation which is...

‘Rabla Auto 2025’ car scrapping programme to begin on Monday with manufacturers validation

The Environmental Fund Administration (AFM) will hold a validation session for manufacturers from 15...

PM Bolojan talks with IMF delegation about economic situation, fiscal reform, public investment priorities

Prime Minister Ilie Bolojan met on Friday at the Victoria Palace with a delegation...

More like this

CNAS announces continuity of treatment for oncology patients

The National Health Insurance House (CNAS) assures oncology patients that it continuously monitors the...

IMF expects gradual increase in Romania’s economy and inflation reduction by end of 2026

Romania's economy is expected to grow gradually, driven by much-needed fiscal consolidation which is...

‘Rabla Auto 2025’ car scrapping programme to begin on Monday with manufacturers validation

The Environmental Fund Administration (AFM) will hold a validation session for manufacturers from 15...